11/14/2024
5:22 PM | EcoR1 Capital, LLC (Filed by)
Edgewise Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
7:59 AM | Edgewise Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
11/12/2024
8:55 AM | Edgewise Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/07/2024
7:53 AM | Edgewise Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2024
7:07 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Edgewise Therapeutics (Subject)
| Form SC 13G | |
|
10/16/2024
3:23 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:22 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:24 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:24 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:25 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:25 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
8:20 PM | Edgewise Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
09/20/2024
4:37 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:46 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:29 PM | Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
4:07 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:06 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
9:10 AM | Edgewise Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
06/12/2024
6:23 PM | Edgewise Therapeutics (Issuer)
Edris Badreddin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:25 PM | Brege Laura (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:26 PM | Edgewise Therapeutics (Issuer)
Morris Arlene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:32 PM | Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:33 PM | Edgewise Therapeutics (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:22 PM | Edgewise Therapeutics (Issuer)
ROOT JONATHAN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
8:09 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
8:07 AM | Edgewise Therapeutics (Filer)
| Form S-3ASR | |
05/10/2024
8:10 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
8:21 AM | Edgewise Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/09/2024
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:06 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:51 PM | Edgewise Therapeutics (Issuer)
Morris Arlene (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/07/2024
6:52 PM | Edgewise Therapeutics (Issuer)
Morris Arlene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:16 AM | Edgewise Therapeutics (Filer)
| Form DEFA14A | |
05/07/2024
8:14 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
5:26 PM | Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:27 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:28 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:29 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
When it comes to NVDA… “acceleration cycles” are the key (Ad) Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options…
By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)...
And thanks to many months and late nights working out the kinks of the systems…
They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! |
05/03/2024
5:30 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:31 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
7:07 AM | Edgewise Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
9:26 AM | Edgewise Therapeutics (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/14/2024
7:43 AM | Deep Track Capital, LP (Filed by)
Edgewise Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
4:42 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:43 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
3:18 PM | Edgewise Therapeutics (Subject)
MOORE JOHN R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
4:28 PM | Edgewise Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
01/29/2024
3:30 PM | Edgewise Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
01/23/2024
3:19 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
3:54 PM | Edgewise Therapeutics (Filer)
| Form 424B5 | |
01/19/2024
7:44 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
5:02 AM | Edgewise Therapeutics (Filer)
| Form 424B3 | |
01/19/2024
5:04 AM | Edgewise Therapeutics (Filer)
| Form S-3MEF | |
01/19/2024
5:05 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:38 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
Fox Jonathan C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:22 PM | Edgewise Therapeutics (Subject)
MOORE JOHN R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:32 PM | Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
